Show simple item record

dc.contributor.authorTang, Tjun Yip
dc.contributor.authorChong, Tze-Tec
dc.contributor.authorYap, Charyl Jia Qi
dc.contributor.authorSoon, Shereen Xue Yun
dc.contributor.authorChan, Sze Ling
dc.contributor.authorTan, Ru Yu
dc.contributor.authorYap, Hao Yun
dc.contributor.authorTay, Hsien Ts'ung
dc.contributor.authorTan, Chieh-Suai
dc.contributor.authorBarnhill, Scott
dc.contributor.authorHellinga, David
dc.contributor.authorDeGraw, R Tyler
dc.contributor.authorFinn, Aloke V
dc.date.accessioned2021-07-15T19:21:33Z
dc.date.available2021-07-15T19:21:33Z
dc.date.issued2021-07-03
dc.identifier.urihttp://hdl.handle.net/10713/16191
dc.description.abstractThe aim of this pilot clinical study is to evaluate the safety and efficacy of the Selution Sustained Limus Release (SLR)™ sirolimus-coated balloon (M.A. MedAlliance SA, Nyon, Switzerland) for improving the patency of failing arterio-venous fistulas (AVF) in hemodialysis patients. We also present herein a pre-clinical pharmacokinetic and safety evaluation of Selution™ to justify its first use in hemodialysis patients for endovascular access salvage.en_US
dc.description.urihttps://doi.org/10.1177/11297298211020867en_US
dc.language.isoenen_US
dc.publisherSAGE Publications Inc.en_US
dc.relation.ispartofJournal of Vascular Accessen_US
dc.subjectSirolimus coated balloonen_US
dc.subjectarterio-venous fistulaen_US
dc.subjectoutcomeen_US
dc.subjectpre-clinical animal modelen_US
dc.subjectsafetyen_US
dc.subjecttarget lesion primary patencyen_US
dc.titleIntervention with selution SLR™ Agent Balloon for Endovascular Latent Limus therapy for failing AV Fistulas (ISABELLA) Trial: Protocol for a pilot clinical study and pre-clinical results.en_US
dc.typeArticleen_US
dc.identifier.doi10.1177/11297298211020867
dc.identifier.pmid34219511
dc.source.beginpage11297298211020867
dc.source.endpage
dc.source.countryUnited States


This item appears in the following Collection(s)

Show simple item record